Brand-name GLP-1 prices without insurance range from $900-$1,400/month. But that's not your only option. Here's every legitimate path to GLP-1 medication in 2026, ranked by actual monthly cost — with nothing left out.
The short answer: If you qualify for the Medicare GLP-1 Bridge, that $50/month copay beats everything else on this list. If you don't, compounded semaglutide through telehealth is the cheapest legal option without insurance — starting around $249/month. Compounded tirzepatide starts around $397/month. These contain the same active molecules as Ozempic, Wegovy, Mounjaro, and Zepbound at a fraction of the brand cost.
See exact pricing for your situation
DirectMeds offers physician-supervised compounded semaglutide and tirzepatide, all-inclusive with no membership fee. Free eligibility check, ships to 48 states.
Check eligibility at DirectMeds →
Full price comparison — every real option in 2026
| Option | Monthly cost | Medication | Notes |
|---|
| Medicare GLP-1 Bridge | $50/mo | Wegovy, Zepbound, or Foundayo | If eligible — Part D + BMI 35+ or qualifying condition |
| Compounded semaglutide (telehealth) | $249–297/mo | Semaglutide | Same active molecule as Ozempic/Wegovy; all-inclusive pricing available |
| Compounded tirzepatide (telehealth) | $397/mo | Tirzepatide | Same active molecule as Mounjaro/Zepbound |
| NovoCare cash program | $499/mo | Wegovy (brand) | If you qualify; directly from Novo Nordisk |
| Lilly Direct self-pay | $349–499/mo | Zepbound (brand) | Vial form; lower dose = lower cost |
| GoodRx on Ozempic | $900–1,100/mo | Ozempic (brand) | Varies heavily by pharmacy and dose |
| Wegovy retail (no insurance) | $1,300+/mo | Wegovy (brand) | Full list price |
| Mounjaro retail (no insurance) | $1,000+/mo | Mounjaro (brand) | Full list price |
Medicare? There's a $50/month option — already live
If you're on Medicare, the calculus is completely different, and it's worth checking first before anything else on this page. The Medicare GLP-1 Bridge program launched July 1, 2026, giving eligible Part D beneficiaries access to Wegovy, Zepbound KwikPen, or Foundayo for a flat $50/month. Eligibility requires BMI 35+ alone, or a lower BMI with specific qualifying conditions. If you qualify, this beats every other option on this page — but the program is scheduled to end December 31, 2027, so see our full breakdown of what happens after it ends before relying on it long-term.
Don't qualify for the Bridge, or want a backup plan?
Compounded semaglutide and tirzepatide through DirectMeds work whether or not you're on Medicare — no waiting on a federal enrollment window.
Check eligibility at DirectMeds →
Why compounded GLP-1 is meaningfully cheaper than brand-name
Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies using the same active pharmaceutical ingredient as the brand-name drugs. They are not generics — generics require patent expiration, which hasn't happened. Compounding is a separate legal pathway that allows pharmacists to prepare individualized medications from scratch, prescribed by a physician for a specific patient.
What you don't pay for: Novo Nordisk's or Eli Lilly's branding, their auto-injector pen devices, their marketing spend, or their manufacturer margin. The active molecule that actually does the work costs less to produce than the brand markup suggests.
2026 regulatory note: Compounded GLP-1 marketing has come under real FDA scrutiny — in September 2025, the FDA sent warning letters to 55+ compounded GLP-1 telehealth companies, including major names in this space, over marketing language implying FDA-approved equivalence. This was an industry-wide sweep about labeling, not a product recall, but it's worth knowing the space isn't without regulatory friction. Always confirm a provider's licensing and read
a specific legitimacy review before enrolling anywhere.
The real cost of "cheapest" — what to watch for
Some providers advertise very low headline prices that obscure the actual ongoing cost:
- Intro-rate traps — month 1 is artificially cheap, months 2+ jump significantly. Always ask what the price is at your full therapeutic dose (typically 1mg semaglutide or 7.5-10mg tirzepatide).
- Required membership fees — some platforms charge a separate monthly "membership" or "telehealth fee" on top of the medication cost. Add these together for the real number — this is exactly what makes Hims's advertised $199/month semaglutide actually closer to $344/month once its $145 membership fee is included.
- Dose-scaling costs — compounded GLP-1 typically costs more at higher doses. Ask for the full titration price schedule upfront, not just the starting-dose price.
- Lab requirements — some platforms require bloodwork before starting. Factor this cost in.
$50
Medicare GLP-1 Bridge copay, if eligible
Through Dec 31, 2027
$249+
Cheapest legal compounded semaglutide, all-inclusive
Telehealth platforms, 2026
$1,300
Wegovy retail price without insurance or programs
What you're avoiding
Not on Medicare, or not sure you qualify?
Compounded semaglutide and tirzepatide remain the most affordable route for most people. Check your eligibility free before committing.
Check eligibility at DirectMeds →
Semaglutide vs tirzepatide — which is cheaper overall?
Semaglutide starts cheaper (~$249 vs ~$397 for tirzepatide), but tirzepatide produces roughly 22% average weight loss versus 15% for semaglutide in general population trial data. On a cost-per-pound-lost basis over 12 months, the numbers are closer than the monthly price difference suggests — and tirzepatide often reaches maintenance sooner, potentially reducing the months you need to stay at higher doses.
For the person asking "what's the absolute cheapest," compounded semaglutide wins. For the person asking "cheapest per outcome," the math gets more nuanced — see our full semaglutide vs tirzepatide comparison for the complete picture.
Ready to check your real price?
DirectMeds offers physician-supervised compounded semaglutide and tirzepatide. Free eligibility check, no insurance required, ships to 48 states.
Check eligibility at DirectMeds →
Frequently asked questions
What is the cheapest GLP-1 medication available in 2026?
Compounded semaglutide through licensed telehealth platforms is among the cheapest legal GLP-1 options without insurance, starting at approximately $249/month. Compounded tirzepatide starts around $397/month. Both contain the same active ingredients as brand-name medications at a fraction of the cost. Medicare beneficiaries who qualify can access Wegovy, Zepbound, or Foundayo for $50/month through the Medicare GLP-1 Bridge program, which launched July 1, 2026.
Is compounded semaglutide safe and legal?
Compounded semaglutide is legal when prepared by a licensed 503A or 503B compounding pharmacy based on an individual physician prescription. It contains the same active pharmaceutical ingredient as Ozempic and Wegovy. It is regulated differently from FDA-approved brand products but is not illegal. Always use a licensed telehealth platform with a licensed pharmacy, and ask directly about the specific pharmacy's licensing.
Why is compounded tirzepatide cheaper than Zepbound?
Compounded tirzepatide skips the brand-name costs: Eli Lilly's manufacturing markup, the proprietary injector pen device, and marketing expenses. The active molecule tirzepatide is prepared directly by a compounding pharmacy from pharmaceutical-grade ingredients at a cost that reflects production rather than brand value. Zepbound's list price of approximately $1,000/month without insurance reflects the full brand commercial structure.
Is the Medicare GLP-1 Bridge still the cheapest option if I qualify?
Yes. The Medicare GLP-1 Bridge, which launched July 1, 2026, offers eligible Part D beneficiaries a flat $50/month copay for Wegovy, Zepbound KwikPen, or Foundayo — cheaper than any compounded option. It's scheduled to run through December 31, 2027. Eligibility requires Medicare Part D coverage plus a BMI of 35+, or a lower BMI with a qualifying condition.